Holen Sie sich die Stockscreener-App
18.58
0.70%
0.13
Handel nachbörslich:
18.58
Schlusskurs vom Vortag:
$18.45
Offen:
$18.52
24-Stunden-Volumen:
600.52K
Relative Volume:
0.96
Marktkapitalisierung:
$1.16B
Einnahmen:
$330.50M
Nettoeinkommen (Verlust:
$145.42M
KGV:
11.26
EPS:
1.65
Netto-Cashflow:
$157.96M
1W Leistung:
+7.52%
1M Leistung:
+1.14%
6M Leistung:
+6.41%
1J Leistung:
+15.40%
1-Tages-Spanne:
$18.44
$18.61
1-Wochen-Bereich:
$17.23
$18.61
52-Wochen-Spanne:
$14.32
$21.28
Innoviva Inc Stock (INVA) Company Profile
Firmenname
Innoviva Inc
Sektor
Branche
Telefon
(650) 238-9600
Adresse
1350 OLD BAYSHORE HIGHWAY, BURLINGAME
Vergleichen Sie INVA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
INVA
Innoviva Inc
|
18.58 | 1.16B | 330.50M | 145.42M | 157.96M | 1.65 |
|
VRTX
Vertex Pharmaceuticals Inc
|
422.00 | 108.68B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
681.58 | 74.90B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
640.52 | 38.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
246.27 | 31.76B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
111.93 | 26.83B | 3.30B | -501.07M | 1.03B | -2.1146 |
Innoviva Inc Stock (INVA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-06-18 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2022-07-20 | Eingeleitet | Goldman | Neutral |
| 2017-11-20 | Eingeleitet | Deutsche Bank | Hold |
Innoviva Inc Aktie (INVA) Neueste Nachrichten
Innoviva (NASDAQ:INVA) investors are up 4.7% in the past week, but earnings have declined over the last five years - Simply Wall St
When (INVA) Moves Investors should Listen - Stock Traders Daily
JPMorgan Chase & Co. Has $11.17 Million Stake in Innoviva, Inc. (NASDAQ:INVA) - Defense World
JPMorgan Chase & Co. Acquires 72,039 Shares of Innoviva, Inc. (NASDAQ:INVA) - MarketBeat
Armata Pharmaceuticals Announces $35 Million Secured Credit Agre - GuruFocus.com
(INVA) Trading Report - Stock Traders Daily
Principal Financial Group Inc. Cuts Holdings in Innoviva, Inc. (NASDAQ:INVA) - Defense World
Innoviva (NASDAQ:INVA) Downgraded to “Hold” Rating by StockNews.com - Defense World
Innoviva (NASDAQ:INVA) Downgraded to Hold Rating by StockNews.com - MarketBeat
Barclays PLC Purchases 72,192 Shares of Innoviva, Inc. (NASDAQ:INVA) - Defense World
Geode Capital Management LLC Has $26.22 Million Stake in Innoviva, Inc. (NASDAQ:INVA) - Defense World
Barclays PLC Acquires 72,192 Shares of Innoviva, Inc. (NASDAQ:INVA) - MarketBeat
Trading (INVA) With Integrated Risk Controls - Stock Traders Daily
Stock Gains You Can't Ignore! - Jomfruland.net
Innoviva's (NASDAQ:INVA) investors will be pleased with their 26% return over the last five years - Yahoo Finance
MML Investors Services LLC Buys 2,985 Shares of Innoviva, Inc. (NASDAQ:INVA) - Defense World
Innoviva, Inc. (NASDAQ:INVA) Shares Bought by Jane Street Group LLC - Defense World
Jane Street Group LLC Increases Position in Innoviva, Inc. (NASDAQ:INVA) - MarketBeat
Fmr LLC Buys 771 Shares of Innoviva, Inc. (NASDAQ:INVA) - Defense World
Wellington Management Group LLP Sells 42,739 Shares of Innoviva, Inc. (NASDAQ:INVA) - MarketBeat
Innoviva, Inc. (NASDAQ:INVA) Shares Sold by HighTower Advisors LLC - Defense World
Innoviva, Inc.'s (NASDAQ:INVA) Popularity With Investors Is Under Threat From Overpricing - Simply Wall St
Oversold Conditions For Innoviva (INVA) - Nasdaq
Innoviva, Inc. (NASDAQ:INVA) Short Interest Down 7.5% in November - Defense World
Innoviva enters distribution, license agreement with Basilea for Zevtera - Yahoo Finance
Innoviva Specialty Therapeutics Signs Exclusive Distribution and Licensing Agreement to Acquire U.S. Marketing Rights for Zevtera® (ceftobiprole) - BioSpace
Innoviva seals deal for new MRSA antibiotic in the US - Investing.com
Innoviva seals deal for new MRSA antibiotic in the US By Investing.com - Investing.com UK
Innoviva Secures Exclusive Rights to Groundbreaking MRSA Antibiotic Zevtera in Major FDA-Approved Drug Deal - StockTitan
Basilea announces agreement with Innoviva Specialty Therapeutics for the commercialization of antibiotic Zevtera® (ceftobiprole) in the United States - The Manila Times
Basilea announces agreement with Innoviva Specialty Therapeutics for the commercialization of antibiotic Zevtera(R) (ceftobiprole) in the United States - Marketscreener.com
Basilea announces agreement with Innoviva Specialty - GlobeNewswire
Basilea Announces Agreement with Innoviva Specialty Therapeutics for the Commercialization of Antibiotic Zevtera (Ceftobiprole) in the United States - Marketscreener.com
How To Trade (INVA) - Stock Traders Daily
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 22,961 Shares of Innoviva, Inc. (NASDAQ:INVA) - Defense World
Walleye Capital LLC Purchases Shares of 11,066 Innoviva, Inc. (NASDAQ:INVA) - Defense World
Charles Schwab Investment Management Inc. Reduces Stock Position in Innoviva, Inc. (NASDAQ:INVA) - Defense World
Charles Schwab Investment Management Inc. Has $14.14 Million Stock Holdings in Innoviva, Inc. (NASDAQ:INVA) - MarketBeat
Systematic Financial Management LP Increases Position in Innoviva, Inc. (NASDAQ:INVA) - MarketBeat
Redwood Investment Management LLC Sells 41,852 Shares of Innoviva, Inc. (NASDAQ:INVA) - MarketBeat
Thrivent Financial for Lutherans Sells 2,384 Shares of Innoviva, Inc. (NASDAQ:INVA) - Defense World
Innoviva to Participate in the Citi 2024 Global Healthcare Conference - BioSpace
Innoviva, Inc. (NASDAQ:INVA) Stake Reduced by Westfield Capital Management Co. LP - MarketBeat
Segall Bryant & Hamill LLC Makes New $715,000 Investment in Innoviva, Inc. (NASDAQ:INVA) - MarketBeat
Victory Capital Management Inc. Grows Stake in Innoviva, Inc. (NASDAQ:INVA) - Defense World
Innoviva, Inc. (NASDAQ:INVA) Shares Sold by Jennison Associates LLC - MarketBeat
Pacer Advisors Inc. Sells 547,610 Shares of Innoviva, Inc. (NASDAQ:INVA) - MarketBeat
Principal Financial Group Inc. Sells 20,058 Shares of Innoviva, Inc. (NASDAQ:INVA) - Defense World
Empowered Funds LLC Has $1.85 Million Stake in Innoviva, Inc. (NASDAQ:INVA) - MarketBeat
Innoviva Reports Strong Q3 Growth Amidst Strategic Advances - TipRanks
US Bancorp DE Has $56,000 Holdings in Innoviva, Inc. (NASDAQ:INVA) - Defense World
Finanzdaten der Innoviva Inc-Aktie (INVA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.65%
4.62%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):